Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy
Open Access
- 27 May 2008
- journal article
- review article
- Published by S. Karger AG in Pharmacology
- Vol. 82 (2), 83-88
- https://doi.org/10.1159/000134943
Abstract
Zidovudine (3-azido-3'-deoxythymidine), also referred to as azidothymidine (AZT), has become an integral component in highly active antiretroviral therapy, and has also been used in the treatment of cancer. The clinical effectiveness of AZT is constrained due to its association with increased adverse effects, such as myopathy. There are numerous potential mechanisms that may contribute to AZT-induced myopathy. The first hypothesized mechanism to explain AZT-induced toxicity was mtDNA depletion due to inhibition of DNA polymerase gamma. Although mtDNA depletion is present in patients with myopathy, current data suggests that alternative mechanisms may play a more direct role in the myotoxicity. These mechanisms include AZT-induced oxidative stress, direct inhibition of mitochondrial bioenergetic machinery, and mitochondrial depletion of L-carnitine. Furthermore, we hypothesize that apoptosis may play a role in AZT-induced myopathy.Keywords
This publication has 42 references indexed in Scilit:
- Uridine supplementation antagonizes zidovudine‐induced mitochondrial myopathy and hyperlactatemia in miceArthritis & Rheumatism, 2007
- Radiosensitization effect of zidovudine on human malignant glioma cellsBiochemical and Biophysical Research Communications, 2007
- 3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondriaBiochemical Pharmacology, 2006
- Cyclic Induction of Senescence with Intermittent AZT Treatment Accelerates both Apoptosis and Telomere LossBreast Cancer Research and Treatment, 2005
- Azidothymidine Induces Apoptosis and Inhibits Cell Growth and Telomerase Activity of Human Parathyroid Cancer Cells in CultureJournal of Bone and Mineral Research, 2005
- Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12Free Radical Biology & Medicine, 2004
- AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins.JCI Insight, 1998
- Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exerciseFEBS Letters, 1995
- AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic FunctionBiochemical and Biophysical Research Communications, 1993
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990